Abstract CT051: Safety and efficacy of CD19/CD22 CAR T cells in children and young adults with relapsed/refractory ALLHaneen Shalabi, Nirali N. Shah, Steven L. Highfill et al.|Cancer Research|2020Cited by 8
Abstract LB-146: Phase I CD22 CAR T-cell trial updatesNirali N. Shah, Terry J. Fry, Haneen Shalabi et al.|Cancer Research|2019Cited by 4